Castration-Sensitive Prostate Carcinoma trials recruiting in Illinois

Fewer than 3 recruiting trials found.

All Castration-Sensitive Prostate Carcinoma trials nationally

Cities in Illinois

Recruiting trials in Illinois

• FDG-PET-Guided Metastasis Directed Radiation Therapy for the Treatment of Metastatic Hormone Sensitive Prostate Cancer, The PRTY Trial
  NCT06244004 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · Illinois: Chicago, DeKalb, Geneva, Oak Brook
• Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
  NCT06931340 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · Illinois: Bloomington, Canton, Carthage, Centralia